TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 31542980

Group type: EXPERIMENTAL
Intervention: Nicotine inhaler (4 mg deliverable)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Nicotine-free inhaler
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Perceived nicotine administration
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Unexpected nicotine administration
Number of subjects: 26
Study: 28100177

Group type: EXPERIMENTAL
Intervention: Desflurane-remifentanil anesthesia
Number of subjects: 103

Group type: COMPARATOR
Intervention: Propofol-remifentanil anesthesia
Number of subjects: 103
Study: 25291152

Group type: EXPERIMENTAL
Intervention: Racemic metoprolol tartrate 100 mg oral dose
Number of subjects: 35
Study: 24026317

Group type: EXPERIMENTAL
Intervention: Social networking intervention via Facebook groups over 12 weeks
Number of subjects: 112

Group type: COMPARATOR
Intervention: Control group (general health information)
Number of subjects: 112

Group type: EXPERIMENTAL
Intervention: Social networking intervention
Number of subjects: 112

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 112
Study: 21796867

Group type: EXPERIMENTAL
Intervention: Biointo (beta-glucan, inositol and digestive enzymes)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control group (no therapy)
Number of subjects: 50
Study: 19182682

Group type: EXPERIMENTAL
Intervention: H. pylori eradication
Number of subjects: 104

Group type: COMPARATOR
Intervention: Antidyspeptic drugs usage
Number of subjects: 104
Study: 17109784

Group type: EXPERIMENTAL
Intervention: Shoulder pillow
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: All pillow conditions
Number of subjects: 40
Study: 14998048

Group type: EXPERIMENTAL
Intervention: Crest SpinBrush Pro with redesigned bristle head
Number of subjects: 44

Group type: COMPARATOR
Intervention: Crest SpinBrush Pro
Number of subjects: 44
Study: 15908730

Group type: EXPERIMENTAL
Intervention: Tot'hema
Number of subjects: 42
Study: 10476342

Group type: EXPERIMENTAL
Intervention: Transmyocardial laser revascularization
Number of subjects: 58
Study: 8731850

Group type: EXPERIMENTAL
Intervention: Cefteram
Number of subjects: 123

Group type: COMPARATOR
Intervention: Cefaclor
Number of subjects: 123
Study: 2036693

Group type: EXPERIMENTAL
Intervention: 1.5 micrograms.kg‐1 fentanyl via a peripheral venous cannula (Group 1)
Number of subjects: 250

Group type: EXPERIMENTAL
Intervention: 0.01 mg.kg‐1 atropine iv one minute before fentanyl (Group 3)
Number of subjects: 250

Group type: EXPERIMENTAL
Intervention: 0.2 mg.kg‐1 morphine im one hour before fentanyl (Group 4)
Number of subjects: 250

Group type: EXPERIMENTAL
Intervention: 7.5 mg midazolam po one hour before fentanyl (Group 5)
Number of subjects: 250

Group type: COMPARATOR
Intervention: saline (Group 2)
Number of subjects: 250
Study: 7272896

Group type: EXPERIMENTAL
Intervention: Protected environment-prophylactic antibiotic (PEPA)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Control group (CYVADIC without PEPA)
Number of subjects: 51
Study: 30496024

Group type: EXPERIMENTAL
Intervention: Long HIIT (3 bouts of 4 min at 90% of vVO2peak, interspersed by 3 min of recovery at 60% of vVO2peak, 21 min total)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Short HIIT (29 bouts of 30s at vVO2peak, interspersed by 30s of passive recovery, 29 min total)
Number of subjects: 10

Group type: COMPARATOR
Intervention: MICT (21 min at 70% of vVO2peak)
Number of subjects: 10
Study: 28270491

Group type: EXPERIMENTAL
Intervention: SENSIMED Triggerfish contact lens in flat sleeping position
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: SENSIMED Triggerfish contact lens in 30° head-up sleeping position
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: SENSIMED Triggerfish contact lens after 24 hours of wear
Number of subjects: 12
Study: 26797215

Group type: EXPERIMENTAL
Intervention: Raltegravir (RAL)
Number of subjects: 328

Group type: COMPARATOR
Intervention: Protease Inhibitors (ATV/r, DRV/r combined)
Number of subjects: 328
Study: 24440643

Group type: EXPERIMENTAL
Intervention: Tai Chi (TC)
Number of subjects: 145

Group type: EXPERIMENTAL
Intervention: Strength and range of movement exercises (SS)
Number of subjects: 145

Group type: COMPARATOR
Intervention: Usual care (UC)
Number of subjects: 145
Study: 22410598

Group type: EXPERIMENTAL
Intervention: Motivational Interviewing Cessation program
Number of subjects: 39

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 39
Study: 20795797

Group type: EXPERIMENTAL
Intervention: doc.com
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: WebEncounter
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: doc.com + WebEncounter
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (WebOSCE assessment only)
Number of subjects: 0
Study: 17627015

Group type: EXPERIMENTAL
Intervention: Colon Cancer Risk Counseling (CCRC)
Number of subjects: 176

Group type: COMPARATOR
Intervention: General Health Counseling (GHC)
Number of subjects: 176
Study: 15818607

Group type: EXPERIMENTAL
Intervention: Jail diversion programs (3 pre-booking and 3 post-booking)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Non-diverted groups
Number of subjects: 0
Study: 11887193

Group type: EXPERIMENTAL
Intervention: sibutramine 10mg
Number of subjects: 86

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 86
Study: 9861551

Group type: EXPERIMENTAL
Intervention: Immediate-release methylphenidate (IR; 20-40 mg)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Sustained-release methylphenidate (SR; 20-40 mg)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 8907212

Group type: EXPERIMENTAL
Intervention: Diet and exercise intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care control
Number of subjects: 0
Study: 2924517

Group type: EXPERIMENTAL
Intervention: Aminophylline
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study: 31491479

Group type: EXPERIMENTAL
Intervention: High-Performing Sites (HPS)
Number of subjects: 2100

Group type: COMPARATOR
Intervention: Low-Performing Sites (LPS)
Number of subjects: 2100

Group type: EXPERIMENTAL
Intervention: HPS
Number of subjects: 2100

Group type: COMPARATOR
Intervention: LPS
Number of subjects: 2100
Study: 30907346

Group type: EXPERIMENTAL
Intervention: Integrated sandplay therapy in addition to routine training
Number of subjects: 44

Group type: COMPARATOR
Intervention: Routine training (Control)
Number of subjects: 44
Study: 27803120

Group type: EXPERIMENTAL
Intervention: Participants with CAN at DCCT closeout
Number of subjects: 1262

Group type: COMPARATOR
Intervention: Participants without CAN at DCCT closeout
Number of subjects: 1262

Group type: EXPERIMENTAL
Intervention: R‐R variation as a continuous variable
Number of subjects: 1262
Study: 26829443

Group type: EXPERIMENTAL
Intervention: Vitamin D (cholecalciferol) 20,000 IU/wk
Number of subjects: 511

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 511
Study: 23855840

Group type: EXPERIMENTAL
Intervention: 0.2% chlorhexidine gluconate
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: herbal mouthwash
Number of subjects: 24

Group type: COMPARATOR
Intervention: water
Number of subjects: 24
Study: 22172564

Group type: EXPERIMENTAL
Intervention: Family-based treatment (FBT)
Number of subjects: 121

Group type: COMPARATOR
Intervention: Individual adolescent focused therapy (AFT)
Number of subjects: 121
Study: 19183412

Group type: EXPERIMENTAL
Intervention: 0.1% bromfenac
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: 0.1% betamethasone
Number of subjects: 72

Group type: EXPERIMENTAL
Intervention: Combined treatment (bromfenac and betamethasone)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Control (not applicable)
Number of subjects: 72
Study: 17964038

Group type: EXPERIMENTAL
Intervention: Percutaneous revascularization during index hospitalization
Number of subjects: 1891

Group type: EXPERIMENTAL
Intervention: Patients with cardiogenic shock
Number of subjects: 1891

Group type: COMPARATOR
Intervention: Patients without shock
Number of subjects: 1891
Study: 15688962

Group type: EXPERIMENTAL
Intervention: Test Dentifrice (sodium bicarbonate, dual-phase dentifrice containing calcium and phosphate)
Number of subjects: 108

Group type: COMPARATOR
Intervention: Control Dentifrice (commercial hydrated silica dentifrice)
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Test Dentifrice
Number of subjects: 108
Study: 12181221

Group type: EXPERIMENTAL
Intervention: Twin-twin transfusion syndrome recipient fetuses
Number of subjects: 136

Group type: COMPARATOR
Intervention: Uncomplicated monochorionic diamniotic twins
Number of subjects: 136

Group type: EXPERIMENTAL
Intervention: Congenital heart disease prevalence in twin-twin transfusion syndrome
Number of subjects: 136

Group type: COMPARATOR
Intervention: Congenital heart disease prevalence in singletons
Number of subjects: 136
Study: 9855322

Group type: EXPERIMENTAL
Intervention: Olanzapine
Number of subjects: 19

Group type: COMPARATOR
Intervention: Cimetidine
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Aminophylline 350 mg
Number of subjects: 19
Study: 7861791

Group type: EXPERIMENTAL
Intervention: Ethanol (1.0 g/kg, divided into two equal doses given 75 minutes apart)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Placebo (similar schedule as ethanol group)
Number of subjects: 37
Study: 2510276

Group type: EXPERIMENTAL
Intervention: Rioprostil, 150 micrograms t.i.d. for 12 weeks
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Rioprostil, 200 micrograms b.i.d. for 12 weeks
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Rioprostil
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 799958

Group type: EXPERIMENTAL
Intervention: Racemic propranolol
Number of subjects: 0

Group type: COMPARATOR
Intervention: Dextrorotatory propranolol
Number of subjects: 0
Study: 31325802

Group type: EXPERIMENTAL
Intervention: Endotoxin administration
Number of subjects: 115

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 115
Study: 28406806

Group type: EXPERIMENTAL
Intervention: One-on-one mentorship for HIV and TB care (8 hours a week for 9 months)
Number of subjects: 40

Group type: COMPARATOR
Intervention: No clinical mentorship (control group)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: On-site clinical mentorship
Number of subjects: 40
Study: 25931433

Group type: EXPERIMENTAL
Intervention: Naltrexone
Number of subjects: 88

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 88
Study: 23883828

Group type: EXPERIMENTAL
Intervention: Artificial disc replacement (Discover artificial disc)
Number of subjects: 136

Group type: COMPARATOR
Intervention: Anterior cervical decompression and fusion (ACDF)
Number of subjects: 136

Group type: COMPARATOR
Intervention: ACDF
Number of subjects: 136
Study: 21972626

Group type: EXPERIMENTAL
Intervention: Electroacupuncture and acupoint injection with Neostigmine (in addition to conventional western medicine)
Number of subjects: 116

Group type: COMPARATOR
Intervention: Conventional western medicine (control group)
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: Electroacupuncture and acupoint injection with Neostigmine
Number of subjects: 116
Study: 18390974

Group type: EXPERIMENTAL
Intervention: Expanded cardiac rehabilitation including stress management, increased physical training, staying at a 'patient hotel' and cooking sessions
Number of subjects: 224

Group type: COMPARATOR
Intervention: Usual cardiac rehabilitation
Number of subjects: 224
Study: 15995103

Group type: COMPARATOR
Intervention: Urine leukotriene B4 (LTB4) levels in patients with FMF (12 patients)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Urine leukotriene B4 (LTB4) levels in patients with other forms of acute right lower abdominal pain (including appendicitis, urologic disorders, nonspecific abdominal pain)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Urine leukotriene B4 (LTB4) levels in healthy control subjects (18 volunteers)
Number of subjects: 36
Study: 12135284

Group type: EXPERIMENTAL
Intervention: Liposomal amphotericin B (AmBisome) at cumulative doses of 3.75 mg/kg for 5 days
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Liposomal amphotericin B (AmBisome) at cumulative doses of 7.5 mg/kg for 5 days
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Liposomal amphotericin B (AmBisome) at cumulative doses of 15.0 mg/kg for 5 days
Number of subjects: 84
Study: 10407512

Group type: EXPERIMENTAL
Intervention: Intermittent exposure to a 60 Hz, 28.3 microT magnetic field
Number of subjects: 24

Group type: COMPARATOR
Intervention: Continuous exposure to a 60 Hz, 28.3 microT magnetic field
Number of subjects: 24

Group type: COMPARATOR
Intervention: Sham exposure
Number of subjects: 24
Study: 7751890

Group type: EXPERIMENTAL
Intervention: Etoposide phosphate with cisplatin
Number of subjects: 0

Group type: COMPARATOR
Intervention: Etoposide with cisplatin
Number of subjects: 0
Study: 2265164

Group type: EXPERIMENTAL
Intervention: Ropivacaine (0.5% to 0.75%)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: Ropivacaine (with epinephrine)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Bupivacaine
Number of subjects: 70
Study: 367414

Group type: EXPERIMENTAL
Intervention: Cinnarizine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 31255890

Group type: EXPERIMENTAL
Intervention: Transversalis Fascia Plane Block (TFPB)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Standard multimodal analgesia (routine paracetamol and tramadol PCA in addition to diclophenac sodium as rescue analgesia)
Number of subjects: 70
Study: 29192967

Group type: EXPERIMENTAL
Intervention: TAP-VA (Tailored Activity Program)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Control (telephone-based dementia education)
Number of subjects: 160
Study: 26401826

Group type: EXPERIMENTAL
Intervention: 2‐DeNT Oral Topical Powder
Number of subjects: 46

Group type: COMPARATOR
Intervention: Placebo control
Number of subjects: 46
Study: 25329470

Group type: EXPERIMENTAL
Intervention: Participatory women's health groups intervention with monthly meetings and a participatory learning and action cycle.
Number of subjects: 6275

Group type: COMPARATOR
Intervention: Usual perinatal care (Control group).
Number of subjects: 6275
Study: 23517050

Group type: EXPERIMENTAL
Intervention: Simulation training program for emergency obstetric and perinatal care
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Increased participation of professional midwives to strengthen the link between traditional birth attendants and the formal health care system
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Social marketing campaign to promote institution-based deliveries
Number of subjects: 15

Group type: COMPARATOR
Intervention: No external intervention planned for control clinics
Number of subjects: 15
Study: 20567002

Group type: EXPERIMENTAL
Intervention: Primary prophylactic granulocyte colony-stimulating factor (PPGCSF)
Number of subjects: 239
Study: 17588824

Group type: EXPERIMENTAL
Intervention: Family-based intervention promoting healthy eating habits and increasing physical activity (n=153).
Number of subjects: 303

Group type: COMPARATOR
Intervention: Alternative intervention promoting general self-esteem and social efficacy (n=150).
Number of subjects: 303
Study: 16161730

Group type: EXPERIMENTAL
Intervention: Washington State Parent‐Child Assistance Program (intervention)
Number of subjects: 216

Group type: COMPARATOR
Intervention: Control group (original demonstration)
Number of subjects: 216
Study: 14633521

Group type: EXPERIMENTAL
Intervention: Desflurane
Number of subjects: 21

Group type: COMPARATOR
Intervention: Propofol
Number of subjects: 21
Study: 10705164

Group type: EXPERIMENTAL
Intervention: Selective reminding procedure (SRP)
Number of subjects: 256

Group type: COMPARATOR
Intervention: MMSE
Number of subjects: 256
Study: 9234028

Group type: EXPERIMENTAL
Intervention: Intervention group (60 g breakfast cereal daily with semi-skimmed milk)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 59
Study: 8383096

Group type: EXPERIMENTAL
Intervention: Ketoconazole 400 mg daily for 7 days
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Itraconazole 200 mg orally, or clotrimazole 200 mg intravaginally, twice weekly for six months
Number of subjects: 100
Study: 3770039

Group type: EXPERIMENTAL
Intervention: Pneumococcal vaccine (Moniarix)
Number of subjects: 47

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 47
Study: 30497534

Group type: EXPERIMENTAL
Intervention: KSR cultivation in Dong villages
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: KSR cultivation area in Congjiang
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: Farmers' attitudes towards KSR
Number of subjects: 156
Study: 27089207

Group type: EXPERIMENTAL
Intervention: Anodal tDCS
Number of subjects: 24

Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 24
Study: 22948250

Group type: EXPERIMENTAL
Intervention: UHF rTMS (30 Hz)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Sham condition
Number of subjects: 43
Study: 20097417

Group type: EXPERIMENTAL
Intervention: Procalcitonin-guided treatment
Number of subjects: 626

Group type: COMPARATOR
Intervention: Control group (standard antibiotic treatment)
Number of subjects: 626
Study: 18607265

Group type: COMPARATOR
Intervention: Standard infant formula (group A)
Number of subjects: 60

Group type: COMPARATOR
Intervention: 5 g of rice cereal added to 100 mL standard formula (group B)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Formula manufactured with bean gum as a thickening agent (group C)
Number of subjects: 60
Study: 15839182

Group type: EXPERIMENTAL
Intervention: Comprehensive diabetes care measures (1999-2001)
Number of subjects: 174

Group type: EXPERIMENTAL
Intervention: Hemoglobin A1c testing
Number of subjects: 174

Group type: EXPERIMENTAL
Intervention: Low-density lipoprotein cholesterol testing
Number of subjects: 174

Group type: EXPERIMENTAL
Intervention: Eye examinations
Number of subjects: 174

Group type: EXPERIMENTAL
Intervention: Low-density lipoprotein cholesterol control
Number of subjects: 174

Group type: EXPERIMENTAL
Intervention: Nephropathy monitoring
Number of subjects: 174
Study: 12429196

Group type: COMPARATOR
Intervention: Parkinson's disease (PD)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Amyotrophic lateral sclerosis (ALS)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Comparison of PD and ALS
Number of subjects: 60
Study: 10918827

Group type: EXPERIMENTAL
Intervention: Treatment in a stroke unit
Number of subjects: 1241

Group type: COMPARATOR
Intervention: General neurological/medical ward
Number of subjects: 1241
Study: 8878223

Group type: EXPERIMENTAL
Intervention: Azithromycin (10 mg/kg once daily for 3 days)
Number of subjects: 343

Group type: COMPARATOR
Intervention: Penicillin V (three times daily for 10 days)
Number of subjects: 343
Study: 1457110

Group type: EXPERIMENTAL
Intervention: Fresh gas flow at N2O 1 L/min and O2 0.6 L/min (Group 1)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Fresh gas flow at N2O 0.5 L/min and O2 0.5 L/min (Group 2)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Moderate surplus of N2O and O2 with respect to the patient's O2 consumption (Group 3)
Number of subjects: 36
Study: 3888246

Group type: COMPARATOR
Intervention: Local methoxsalen (13 cases)
Number of subjects: 84

Group type: COMPARATOR
Intervention: Etretinate (20 cases)
Number of subjects: 84

Group type: COMPARATOR
Intervention: Oral methoxsalen (13 cases)
Number of subjects: 84

Group type: COMPARATOR
Intervention: 1% methoxsalen cream (33 cases)
Number of subjects: 84

Group type: COMPARATOR
Intervention: Trioxsalen baths (18 cases)
Number of subjects: 84
Study: 31861038

Group type: EXPERIMENTAL
Intervention: Intravenous cannula
Number of subjects: 71

Group type: COMPARATOR
Intervention: Conventional needle
Number of subjects: 71
Study: 29399799

Group type: EXPERIMENTAL
Intervention: Intravenous plus intra-articular tranexamic acid (20 mg/kg intravenous and 3.0 g intra-articular)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Intra-articular tranexamic acid alone (3.0 g intra-articular and normal saline intravenous)
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Intravenous plus intra-articular tranexamic acid
Number of subjects: 96
Study: 27457721

Group type: EXPERIMENTAL
Intervention: Psychological skills training (PST)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Mindfulness-based intervention (MI)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Waiting-list control group
Number of subjects: 0
Study: 23200161

Group type: EXPERIMENTAL
Intervention: Positive affect
Number of subjects: 1375

Group type: COMPARATOR
Intervention: Control (low positive affect)
Number of subjects: 1375
Study: 21844506

Group type: EXPERIMENTAL
Intervention: Early endoscopic ultrasound-guided celiac plexus neurolysis (EUS-CPN)
Number of subjects: 96

Group type: COMPARATOR
Intervention: Conventional pain management
Number of subjects: 96
Study: 19575807

Group type: COMPARATOR
Intervention: Post-program group (multidisciplinary breast cancer care units)
Number of subjects: 41833

Group type: EXPERIMENTAL
Intervention: Screening group (after invitation to screening)
Number of subjects: 41833

Group type: COMPARATOR
Intervention: Pre-program group (before mammography screening)
Number of subjects: 41833

Group type: COMPARATOR
Intervention: Post-program group vs Pre-program group
Number of subjects: 41833
Study: 17074952

Group type: EXPERIMENTAL
Intervention: Treatment as usual plus contingency management
Number of subjects: 113

Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 113
Study: 15284214

Group type: EXPERIMENTAL
Intervention: Estradiol 1 mg + Dydrogesterone 5 mg (group D)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Estradiol 1 mg + Norethisterone 0.5 mg (group N)
Number of subjects: 38
Study: 11716200

Group type: EXPERIMENTAL
Intervention: Lactose (doses ranging from 6.25 mg to 100 mg)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Lactose (higher than normal clinical doses)
Number of subjects: 19
Study: 9158265

Group type: EXPERIMENTAL
Intervention: HFA-134a beclomethasone dipropionate (HFA-BDP)
Number of subjects: 68

Group type: COMPARATOR
Intervention: CFC-beclomethasone dipropionate (CFC-BDP)
Number of subjects: 68
Study: 7970121

Group type: EXPERIMENTAL
Intervention: Intraperitoneal urokinase
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 24
Study: 2852903

Group type: EXPERIMENTAL
Intervention: Nedocromil sodium 4 mg
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Nedocromil sodium 2 mg
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study: 30734583

Group type: EXPERIMENTAL
Intervention: Neurofeedback (NF)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Waiting list control
Number of subjects: 32